September 28, 2022
Trending Tags

Bausch Health suspends plans for Solta IPO

Read Time:1 Minute, 4 Second


June 16 (Reuters) – Bausch Health Companies Inc (BHC.TO) said on Thursday it was suspending plans for the initial public offering of its unit Solta Medical due to challenging market conditions.

It has been a gloomy year for U.S. capital markets, with IPO-bound Reddit Inc and Mobileye, the self-driving car unit of Intel Corp (INTC.O), facing challenges. read more

The Ukraine conflict and fears over the Federal Reserve’s policy tightening have in recent months forced several companies to postpone or shelve their plans to go public in the United States.

Register now for FREE unlimited access to Reuters.com

Bausch, previously known as Valeant Pharmaceuticals, said it would revisit alternative paths for medical aesthetics company Solta in future.

In August, Bausch announced plans to pursue an IPO of Solta in a bid to shed non-core assets and cut down debt. read more

The Canadian company’s debt piled up due to aggressive deal-making under former Chief Executive Officer Mike Pearson.

The company’s eye-care unit, Bausch + Lomb (BLCO.TO), was recently listed in the United States and Canada.

Register now for FREE unlimited access to Reuters.com

Reporting by Leroy Leo in Bengaluru; Editing by Maju Samuel

Our Standards: The Thomson Reuters Trust Principles.



Source link

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Tom Hanks shout at fans for causing wife to stumble | Entertainment
Next post Michigan Sports Hall of Fame announces 2022 class